1. Home
  2. WEX vs PTCT Comparison

WEX vs PTCT Comparison

Compare WEX & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEX
  • PTCT
  • Stock Information
  • Founded
  • WEX 1983
  • PTCT 1998
  • Country
  • WEX United States
  • PTCT United States
  • Employees
  • WEX N/A
  • PTCT N/A
  • Industry
  • WEX Business Services
  • PTCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEX Consumer Discretionary
  • PTCT Health Care
  • Exchange
  • WEX Nasdaq
  • PTCT Nasdaq
  • Market Cap
  • WEX 5.8B
  • PTCT 4.8B
  • IPO Year
  • WEX 2005
  • PTCT 2013
  • Fundamental
  • Price
  • WEX $158.34
  • PTCT $64.80
  • Analyst Decision
  • WEX Hold
  • PTCT Buy
  • Analyst Count
  • WEX 13
  • PTCT 14
  • Target Price
  • WEX $180.91
  • PTCT $67.00
  • AVG Volume (30 Days)
  • WEX 331.5K
  • PTCT 1.3M
  • Earning Date
  • WEX 10-23-2025
  • PTCT 11-06-2025
  • Dividend Yield
  • WEX N/A
  • PTCT N/A
  • EPS Growth
  • WEX 37.64
  • PTCT N/A
  • EPS
  • WEX 7.93
  • PTCT 7.72
  • Revenue
  • WEX $2,598,200,000.00
  • PTCT $1,764,929,000.00
  • Revenue This Year
  • WEX $1.02
  • PTCT $119.89
  • Revenue Next Year
  • WEX $5.27
  • PTCT N/A
  • P/E Ratio
  • WEX $20.00
  • PTCT $8.47
  • Revenue Growth
  • WEX N/A
  • PTCT 96.00
  • 52 Week Low
  • WEX $110.45
  • PTCT $34.57
  • 52 Week High
  • WEX $217.47
  • PTCT $67.40
  • Technical
  • Relative Strength Index (RSI)
  • WEX 40.27
  • PTCT 68.45
  • Support Level
  • WEX $156.09
  • PTCT $57.74
  • Resistance Level
  • WEX $161.95
  • PTCT $67.40
  • Average True Range (ATR)
  • WEX 4.15
  • PTCT 2.27
  • MACD
  • WEX -0.58
  • PTCT 0.15
  • Stochastic Oscillator
  • WEX 12.08
  • PTCT 73.08

About WEX WEX Inc. common stock

WEX Inc is a provider of corporate payment solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. The company's prime end market is the United States of America.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: